
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-09-07-2016
- Volume 11
- Issue 9
Recipharm Expands Lyophilization Capacity in Italy
Recipharm is investing EUR3.7 million (approximately $4.18 million) to increase lyophilization capacity at its Masate facility in Italy.
CDMO Recipharm has
The CDMO offers lyophilization services for both vials and ampoules. The Masate facility specializes in aseptic manufacturing of parenterals.
Recipharm also invested EUR32 million (approximately $36 million) in Wasserburg, Germany in an ongoing project to increase lyophilization capacity at that site.
Source:
Articles in this issue
over 9 years ago
Putting Shelf-Life to the Testover 9 years ago
The Enzymatic Catalysis Route to Going Greenover 9 years ago
CMOs Step Up to Test New Bioprocessing Technologyover 9 years ago
SGS Opens New Facility in Wiesbaden, Germanyover 9 years ago
CSafe Acquires Kalliboxover 9 years ago
CordenPharma in France Reports Successful FDA Inspectionover 9 years ago
Automated Infrared Microscope Effectively Analyzes Micro Samplesover 9 years ago
Eppendorf Expands Single-Use Vessel Portfolioover 9 years ago
PANalytical launches the Empyrean Nano editionNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





